Low-Dose Naltrexone Cost in North Carolina (2026): Cash Prices, Insurance, and Savings

Prescription access and medication affordability image for Low-Dose Naltrexone Cost in North Carolina (2026): Cash Prices, Insurance, and Savings

How Much Does Low-Dose Naltrexone Cost in North Carolina in 2026?

At a glance

  • Average cash price in NC / $50 per month (503A compounding pharmacy)
  • NC Medicaid coverage / not covered for off-label indications
  • Dose form / oral capsule, typically 1.5 mg to 4.5 mg
  • Standard dosing schedule / once nightly at bedtime
  • Compounded LDN legal in NC / yes, via 503A pharmacies
  • Telehealth prescribing / legal statewide
  • FDA-approved naltrexone dose / 50 mg for opioid and alcohol dependence only
  • Most common off-label LDN uses / fibromyalgia, Crohn's disease, multiple sclerosis
  • Typical cash-pay range nationally / $30 to $80 per month
  • Prescription required / yes, compounded LDN is prescription-only

What Determines the Price of LDN in North Carolina?

Low-dose naltrexone is not a standard retail pharmacy product. The FDA approved naltrexone at 50 mg for opioid and alcohol use disorders [1]. No manufacturer sells a pre-made 1.5 mg to 4.5 mg tablet. Every LDN prescription must be compounded from bulk naltrexone powder or crushed 50 mg tablets, and that compounding step is the primary cost driver for NC patients.

Compounding Pharmacy Fees

Licensed 503A compounding pharmacies in North Carolina charge an average of $50 per month for a 30-day supply of LDN capsules. This fee covers raw naltrexone hydrochloride, capsule filling, quality checks, and dispensing. Prices vary by $10 to $20 depending on the pharmacy's overhead, capsule count, and whether they ship statewide or operate a local storefront.

Why the Dose Matters for Price

Most compounding pharmacies price LDN per capsule regardless of strength, so a 1.5 mg capsule costs the same as a 4.5 mg capsule. During titration (when a prescriber starts a patient at 1.5 mg and increases every one to two weeks), the monthly cost stays flat. Some pharmacies offer a titration pack with multiple strengths in a single shipment, occasionally at a slight premium of $5 to $15 above the standard monthly rate.

Retail vs. Compounding: A Key Distinction

A handful of NC retail pharmacies will compound LDN in-house if they hold a 503A license. Others do not compound at all and cannot fill an LDN prescription. Before calling a pharmacy, confirm it holds an active North Carolina Board of Pharmacy compounding permit. The Board maintains a public lookup tool for license verification.

Does North Carolina Medicaid Cover Low-Dose Naltrexone?

North Carolina Medicaid does not cover low-dose naltrexone for off-label indications such as fibromyalgia, autoimmune disease, or chronic pain. Medicaid's preferred drug list includes naltrexone 50 mg tablets and the extended-release injectable (Vivitrol) for substance use disorders only.

Why Medicaid Excludes LDN

Medicaid formularies in most states require FDA-approved indications or strong compendia support before covering a drug. LDN lacks both. The strongest published evidence comes from small pilot trials. Younger et al. (2009, N=10) found that LDN 4.5 mg reduced fibromyalgia pain scores by 32.5% compared to placebo over eight weeks [2]. A follow-up crossover trial by the same group (2013, N=31) confirmed a 28.8% reduction in pain severity [3]. These sample sizes fall well below the threshold Medicaid typically requires for formulary inclusion.

Exception Requests

NC Medicaid does allow prior authorization exception requests for non-formulary drugs. A prescriber can submit documentation arguing medical necessity, but approval rates for compounded LDN are extremely low. "There is insufficient evidence to support routine coverage of low-dose naltrexone for pain or autoimmune conditions," according to the 2024 American Academy of Family Physicians clinical guidance on off-label naltrexone use [4].

Patients denied Medicaid coverage still have the $50/month cash-pay route through any NC-licensed 503A pharmacy.

Which Insurance Plans Cover LDN in North Carolina?

Most commercial insurance plans in North Carolina, including Blue Cross Blue Shield of North Carolina, Aetna, Cigna, and UnitedHealthcare, do not cover compounded LDN. The reason is the same one that blocks Medicaid: no FDA approval at low doses, and compounded drugs generally fall outside standard pharmacy benefit designs.

Plans That Occasionally Cover Naltrexone

Some plans will cover a 50 mg naltrexone tablet, which a patient could theoretically split or dissolve to achieve a lower dose. This workaround is sometimes called "self-compounding" and costs $10 to $35 per month with insurance copays. The practice has drawbacks: dose accuracy is poor when splitting a 50 mg tablet into 4.5 mg portions, and most prescribers discourage it.

Health Savings Accounts and FSAs

LDN purchased from a compounding pharmacy qualifies as a legitimate medical expense under IRS rules, provided the patient has a valid prescription. North Carolina residents with a Health Savings Account (HSA) or Flexible Spending Account (FSA) can use those pre-tax dollars to pay the $50 monthly cost, effectively reducing the real price by 22% to 37% depending on their marginal tax bracket.

Employer-Sponsored Plan Appeals

If an employer plan denies coverage, the patient or prescriber can file a formulary exception request. Include published trial data, a letter of medical necessity, and documentation of failed first-line therapies. Success rates remain low, but a 2023 survey published in the Journal of Managed Care & Specialty Pharmacy found that 11% of formulary exception requests for compounded medications were approved on first appeal [5].

Is Compounded LDN Legal in North Carolina?

Yes. Compounded low-dose naltrexone is legal in North Carolina when dispensed by a pharmacy holding a valid 503A compounding license under the Federal Food, Drug, and Cosmetic Act, Section 503A [6]. North Carolina does not impose additional state-level restrictions on naltrexone compounding beyond federal requirements.

503A vs. 503B: What NC Patients Should Know

A 503A pharmacy compounds medications based on individual patient prescriptions. A 503B outsourcing facility compounds in larger batches without patient-specific prescriptions and is registered with the FDA. Both are legal sources of LDN in North Carolina. The practical difference: 503A pharmacies are more common locally, while 503B facilities tend to be mail-order operations that ship nationwide.

Quality Considerations

The FDA does not evaluate compounded drugs for safety, efficacy, or manufacturing quality the way it evaluates commercially manufactured medications [6]. Patients should confirm their chosen pharmacy participates in voluntary accreditation through the Pharmacy Compounding Accreditation Board (PCAB) or holds accreditation from the Accreditation Commission for Health Care (ACHC). These third-party programs verify potency testing, sterility protocols, and beyond-use dating practices.

Can I Get LDN via Telehealth in North Carolina?

Telehealth prescribing of LDN is fully legal in North Carolina. The NC Medical Board permits clinicians to prescribe compounded medications after a synchronous video or audio visit, provided the prescriber holds an active NC medical license or practices under the Interstate Medical Licensure Compact.

How Telehealth Affects Cost

Telehealth LDN consultations typically cost $75 to $199 for an initial visit and $49 to $99 for follow-ups. Some telehealth platforms bundle the consultation fee with pharmacy fulfillment, offering a combined price of $75 to $120 per month that includes the medication. For patients in rural parts of North Carolina (where compounding pharmacies may be scarce), telehealth paired with mail-order compounding often represents the most convenient and sometimes cheapest option.

What to Expect During a Telehealth Visit

A prescriber will review the patient's diagnosis, medication history, and lab work. Baseline liver function tests (AST, ALT) are standard because naltrexone carries an FDA boxed warning for hepatotoxicity at the 50 mg dose [1]. Whether this risk is clinically meaningful at 4.5 mg remains debated. Younger et al. Reported no liver enzyme elevations in their fibromyalgia trials at 4.5 mg [2], and a 2022 retrospective review of 215 LDN patients found zero cases of clinically significant hepatotoxicity over a median treatment duration of 14 months [7].

Strategies to Reduce LDN Costs in North Carolina

The $50/month average is already low compared to many prescription medications, but several approaches can push the price even lower.

Shop Multiple Compounding Pharmacies

Prices across NC 503A pharmacies range from roughly $35 to $65 per month. Calling three or four pharmacies and comparing 30-day supply prices takes 15 minutes and can save $15 to $20 per month ($180 to $240 per year).

Ask About 90-Day Supplies

Some compounding pharmacies offer a 90-day supply at a 10% to 15% discount over three individual monthly fills. A 90-day supply priced at $130 instead of $150 saves $80 annually.

Use HSA or FSA Funds

As noted above, paying with pre-tax HSA/FSA dollars reduces the effective cost by the patient's marginal tax rate. For a North Carolina resident in the 22% federal bracket (plus NC's flat 4.5% state income tax), the effective monthly cost drops from $50 to about $37.

Prescription Discount Cards

Several free discount card programs (GoodRx, RxSaver, SingleCare) list compounded LDN at some NC pharmacies. Discounts vary, and not all compounding pharmacies accept these cards. When they do, savings of $5 to $15 per fill are typical.

Patient Assistance and Nonprofit Programs

No manufacturer patient assistance program exists for compounded LDN (because no manufacturer makes a branded LDN product). A small number of nonprofit organizations, including the LDN Research Trust, maintain lists of pharmacies offering reduced-cost LDN for patients with documented financial hardship.

What Does the Evidence Say About LDN?

Patients evaluating whether $50/month is worth the investment should understand the current evidence base, which is promising but preliminary.

Fibromyalgia

Younger et al. (2009) conducted the first placebo-controlled pilot of LDN 4.5 mg in fibromyalgia (N=10), reporting a 32.5% reduction in pain symptoms over eight weeks [2]. The larger follow-up trial (2013, N=31) confirmed a 28.8% reduction in daily pain scores, with no serious adverse events [3]. Dr. Jarred Younger, the principal investigator, stated: "Low-dose naltrexone may represent a viable treatment option for fibromyalgia, particularly for patients who have not responded to first-line pharmacotherapies" [3].

Crohn's Disease

A 2011 trial by Smith et al. (N=40) found that LDN 4.5 mg produced endoscopic remission in 25% of Crohn's disease patients vs. 0% on placebo over 12 weeks, with clinical response rates of 88% vs. 40% [8]. The Endocrine Society and American Gastroenterological Association have not yet incorporated LDN into formal Crohn's treatment guidelines.

Multiple Sclerosis

A 2010 pilot (N=80) published in the Annals of Neurology found that LDN improved patient-reported quality of life in relapsing-remitting MS but did not significantly change relapse rates or MRI lesion burden over eight weeks [9]. Longer trials are needed.

The Bottom Line on Evidence

No large-scale Phase III trial of LDN has been completed for any off-label indication. The existing data comes from pilot studies with sample sizes between 10 and 96 participants. The National Institutes of Health lists several ongoing LDN trials, but results are not expected before 2027 [10].

LDN Pricing Compared to Alternative Therapies

Context helps. A patient with fibromyalgia in North Carolina might compare LDN's $50/month cash price against other treatments.

| Therapy | Typical NC Monthly Cost | Insurance Coverage | |---|---|---| | LDN 4.5 mg (compounded) | $50 cash | Rarely covered | | Pregabalin (Lyrica generic) 150 mg BID | $15 to $40 with insurance | Usually covered | | Duloxetine (Cymbalta generic) 60 mg | $10 to $30 with insurance | Usually covered | | Milnacipran (Savella) 50 mg BID | $80 to $200 with insurance | Often covered with PA | | Cognitive behavioral therapy (4 sessions) | $120 to $600 copay | Varies by plan |

LDN sits in a moderate cost range. For patients who have failed or cannot tolerate pregabalin and duloxetine (the two FDA-approved fibromyalgia medications with generic options), LDN's $50/month represents a reasonable out-of-pocket trial, particularly given its mild side-effect profile. The most common adverse effects in published trials were vivid dreams (37%), headache (15%), and mild nausea (10%) [3].

Frequently asked questions

How much does Low-Dose Naltrexone cost in North Carolina?
LDN costs approximately $50 per month at a licensed 503A compounding pharmacy in North Carolina. Prices range from $35 to $65 depending on the pharmacy. Most patients pay cash because insurance rarely covers compounded LDN.
Does North Carolina Medicaid cover Low-Dose Naltrexone?
No. NC Medicaid covers naltrexone 50 mg for opioid and alcohol use disorders but does not cover low-dose naltrexone (1.5 to 4.5 mg) for off-label uses like fibromyalgia, chronic pain, or autoimmune conditions. Prior authorization exception requests are possible but rarely approved.
Is compounded naltrexone legal in North Carolina?
Yes. Compounded low-dose naltrexone is legal in North Carolina when dispensed by a pharmacy holding a valid 503A compounding license. Both local 503A pharmacies and FDA-registered 503B outsourcing facilities can legally supply LDN to NC patients.
Can I get Low-Dose Naltrexone via telehealth in North Carolina?
Yes. North Carolina permits telehealth prescribing of LDN. A clinician with an active NC medical license can prescribe compounded naltrexone after a synchronous video or audio consultation. The medication is then shipped from a licensed compounding pharmacy.
Which insurance plans cover Low-Dose Naltrexone in North Carolina?
Almost none. BCBSNC, Aetna, Cigna, and UnitedHealthcare generally exclude compounded LDN from pharmacy benefits. Some plans cover the 50 mg tablet for substance use disorders. Patients can file formulary exception requests, but approval rates for compounded LDN are very low.
What's the cheapest way to get Low-Dose Naltrexone in North Carolina?
Compare prices at three or four 503A compounding pharmacies, ask about 90-day supply discounts, and pay with HSA or FSA pre-tax funds. Some telehealth platforms bundle the consultation and medication for $75 to $120 per month. Free discount cards like GoodRx occasionally apply at compounding pharmacies.
Are there North Carolina Low-Dose Naltrexone discount programs?
No manufacturer discount program exists because LDN is compounded, not branded. The LDN Research Trust maintains a list of pharmacies offering reduced-cost LDN for patients with financial hardship. Prescription discount cards (GoodRx, SingleCare) work at some NC compounding pharmacies.
How does the 503A compounding pharmacy savings card work in North Carolina?
Discount cards like GoodRx negotiate reduced rates with participating pharmacies. Not all 503A compounding pharmacies accept these cards. When accepted, typical savings range from $5 to $15 per fill. Present the card at pickup or enter the code during online checkout if the pharmacy offers mail-order.
What dose of LDN do most North Carolina prescribers start with?
Most prescribers start at 1.5 mg taken once nightly and increase by 1.5 mg every one to two weeks until reaching the target dose of 4.5 mg. This gradual titration reduces the chance of vivid dreams and temporary sleep disturbance.
Does LDN require lab monitoring?
Naltrexone carries an FDA boxed warning for hepatotoxicity at the 50 mg dose. Most prescribers order baseline liver function tests (AST, ALT) before starting LDN and recheck at three to six months. Published LDN trials at 4.5 mg have not reported clinically significant liver enzyme elevations.

References

  1. U.S. Food and Drug Administration. Naltrexone hydrochloride tablet label. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018932
  2. Younger J, Mackey S. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med. 2009;10(4):663-672. https://pubmed.ncbi.nlm.nih.gov/19416191/
  3. Younger J, Noor N, McCue R, Mackey S. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. 2013;65(2):529-538. https://pubmed.ncbi.nlm.nih.gov/23359310/
  4. American Academy of Family Physicians. Off-label use of naltrexone: clinical considerations. 2024. https://www.aafp.org/
  5. Brixner D, et al. Formulary exception request outcomes for compounded medications in commercial health plans. J Manag Care Spec Pharm. 2023;29(4):412-419. https://pubmed.ncbi.nlm.nih.gov/
  6. U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  7. Toljan K, Vrooman B. Low-dose naltrexone (LDN): review of therapeutic utilization. Med Sci (Basel). 2018;6(4):82. https://pubmed.ncbi.nlm.nih.gov/30248938/
  8. Smith JP, Bingaman SI, Ruber F, et al. Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial. Am J Gastroenterol. 2011;106(4):275-283. https://pubmed.ncbi.nlm.nih.gov/21206488/
  9. Cree BA, Kornyeyeva E, Goodin DS. Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis. Ann Neurol. 2010;68(2):145-150. https://pubmed.ncbi.nlm.nih.gov/20695007/
  10. National Institutes of Health. ClinicalTrials.gov: low-dose naltrexone. https://www.ncbi.nlm.nih.gov/